论文部分内容阅读
选取60例慢性胃炎者给予奥美拉唑联合克拉霉素作为观察组,另外再选取以往单纯给予质子泵抑制剂治疗的慢性胃炎者58例作对比观察,即对照组,同时对两组患者临床治疗效果、用药期间不良事件加以观察和数据的对比、处理与分析。观察组临床治疗总有效率达91.67%、高于对照组(P<0.05),且两组患者不良事件发生率相比无明显差异(P>0.05)。奥美拉唑联合克拉霉素治疗慢性胃炎具有高效、安全等特点,值得临床推广。
60 patients with chronic gastritis were given omeprazole combined with clarithromycin as the observation group, and then select the previous pure proton pump inhibitor treatment of chronic gastritis in 58 patients for comparison, that is, the control group, while the two groups of patients Treatment effect, adverse events observed during treatment and data comparison, processing and analysis. The total effective rate in clinical observation group was 91.67%, higher than that in control group (P <0.05). There was no significant difference between the two groups in the incidence of adverse events (P> 0.05). Omeprazole combined with clarithromycin in the treatment of chronic gastritis with high efficiency, safety and other characteristics, it is worth clinical promotion.